{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:46:14Z","timestamp":1777319174842,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00259-026-07793-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T04:28:35Z","timestamp":1770870515000},"page":"4059-4068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Achieved lipid levels and long-term myocardial perfusion assessed by serial CZT-SPECT in post-PCI anterior myocardial infarction"],"prefix":"10.1007","volume":"53","author":[{"given":"Ya","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinge","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"18","key":"7793_CR1","doi-asserted-by":"publisher","first-page":"e034748","DOI":"10.1161\/JAHA.123.034748","volume":"13","author":"S de Waha","year":"2024","unstructured":"de Waha S, Patel MR. Relationship between infarct Artery, myocardial Injury, and outcomes after primary percutaneous coronary intervention in ST-Segment-Elevation myocardial infarction. J Am Heart Association. 2024;13(18):e034748.","journal-title":"J Am Heart Association"},{"issue":"8","key":"7793_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.amjcard.2017.12.037","volume":"121","author":"T Huynh","year":"2018","unstructured":"Huynh T, Montigny M, Iftikhar U, Gagnon R, Eisenberg M, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, et al. Recurrent cardiovascular events in survivors of myocardial infarction with ST-Segment elevation (from the AMI-QUEBEC Study). Am J Cardiol. 2018;121(8):897\u2013902.","journal-title":"Am J Cardiol"},{"issue":"1","key":"7793_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12265-021-10148-2","volume":"15","author":"Y Ren","year":"2022","unstructured":"Ren Y, Pan W, Li X, Wang S, Lv H, Yu Y, Wang M, Xia Y, Yin D. The predictive value of Lp(a) for adverse cardiovascular event in ACS patients with an achieved LDL-C target at follow up after PCI. J Cardiovasc Transl Res. 2022;15(1):67\u201374.","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"7793_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12872-021-01979-7","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, He L. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. BMC Cardiovasc Disord. 2021;21(1):169.","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"7793_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.5551\/jat.38794","volume":"24","author":"S Suwa","year":"2017","unstructured":"Suwa S, Ogita M, Miyauchi K, Sonoda T, Konishi H, Tsuboi S, Wada H, Naito R, Dohi T, Kasai T, et al. Impact of lipoprotein (a) on Long-Term outcomes in patients with coronary artery disease treated with Statin after a first percutaneous coronary intervention. J Atheroscler Thromb. 2017;24(11):1125\u201331.","journal-title":"J Atheroscler Thromb"},{"issue":"11","key":"7793_CR6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1253\/circj.CJ-23-0200","volume":"87","author":"X Feng","year":"2023","unstructured":"Feng X, Xu Y, Zeng M, Qin Y, Weng Z, Sun Y, Gao Z, He L, Zhao C, Wang N, et al. Optical coherence tomography assessment of coronary lesions associated with microvascular dysfunction in ST-Segment elevation myocardial infarction. Circulation Journal: Official J Japanese Circulation Soc. 2023;87(11):1625\u201332.","journal-title":"Circulation Journal: Official J Japanese Circulation Soc"},{"issue":"8","key":"7793_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.5551\/jat.ED224","volume":"30","author":"S Abe","year":"2023","unstructured":"Abe S. Oxysterol: residual lipid risk for interventional cardiology. J Atheroscler Thromb. 2023;30(8):859\u201360.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"7793_CR8","first-page":"55","volume":"13","author":"RA Byrne","year":"2024","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024;13(1):55\u2013161.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"7793_CR9","doi-asserted-by":"crossref","unstructured":"Toth PP, Worthy G, Gandra SR, Sattar N, Bray S, Cheng LI, Bridges I, Worth GM, Dent R, Forbes CA et al. Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia. J Am Heart Assoc 2017;6(10):e005367.","DOI":"10.1161\/JAHA.116.005367"},{"issue":"9","key":"7793_CR10","doi-asserted-by":"publisher","first-page":"e074067","DOI":"10.1136\/bmjopen-2023-074067","volume":"13","author":"X Ye","year":"2023","unstructured":"Ye X, Wang S, Liu X, Wu Q, Lv Y, Lv Q, Li J, Li L, Yang Y. Effects of PCSK9 inhibitors on coronary microcirculation, inflammation and cardiac function in patients with CHD after PCI: a protocol for systematic review and meta-analysis. BMJ Open. 2023;13(9):e074067.","journal-title":"BMJ Open"},{"issue":"7","key":"7793_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10554-017-1084-4","volume":"33","author":"RS Driessen","year":"2017","unstructured":"Driessen RS, Raijmakers PG, Stuijfzand WJ, Knaapen P. Myocardial perfusion imaging with PET. Int J Cardiovasc Imaging. 2017;33(7):1021\u201331.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"7793_CR12","first-page":"344","volume":"60","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2007;60(6):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"7793_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569\u2013619.","journal-title":"Eur Heart J"},{"issue":"1","key":"7793_CR14","first-page":"539","volume":"18","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the Council on clinical cardiology of the American heart association. Int J Cardiovasc Imaging. 2002;18(1):539\u201342.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"7793_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/EDE.0000000000001730","volume":"35","author":"R Sloot","year":"2024","unstructured":"Sloot R, Breskin A, Colantonio LD, Allmon AG, Yu Y, Sakhuja S. Comparing PCSK9 monoclonal antibody treatment strategies following myocardial infarction using negative control outcomes: A target trial emulation study. Epidemiology. 2024;35(4):579\u201388.","journal-title":"Epidemiology"},{"issue":"2","key":"7793_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ehjci\/jeab034","volume":"23","author":"H Ota","year":"2022","unstructured":"Ota H, Omori H, Kawasaki M, Hirakawa A, Matsuo H. Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study. Eur Heart J Cardiovasc Imaging. 2022;23(2):217\u201328.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"7793_CR17","first-page":"5129","volume":"15","author":"J Yang","year":"2023","unstructured":"Yang J, Ma X, Niu D, Sun Y, Chai X, Deng Y, Wang J, Dong J. PCSK9 inhibitors suppress oxidative stress and inflammation in atherosclerotic development by promoting macrophage autophagy. Am J Translational Res. 2023;15(8):5129\u201344.","journal-title":"Am J Translational Res"},{"issue":"10","key":"7793_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11883-019-0802-x","volume":"21","author":"J Brandts","year":"2019","unstructured":"Brandts J, M\u00fcller-Wieland D. PCSK9 inhibition: new treatment options and perspectives to lower atherogenic lipoprotein particles and cardiovascular risk. Curr Atheroscler Rep. 2019;21(10):40.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"7793_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","volume":"67","author":"RC Hoogeveen","year":"2021","unstructured":"Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: Remnants, Lipoprotein(a), and inflammation. Clin Chem. 2021;67(1):143\u201353.","journal-title":"Clin Chem"},{"key":"7793_CR20","doi-asserted-by":"crossref","unstructured":"Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, Padmanabhan L, Glynn RJ, Ridker PM, Chasman DI et al. Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol. J Am Heart Assoc 2017;6(7):e005549.","DOI":"10.1161\/JAHA.117.005549"},{"issue":"22","key":"7793_CR21","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, Bhatt DL. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097\u2013107.","journal-title":"N Engl J Med"},{"key":"7793_CR22","doi-asserted-by":"publisher","first-page":"1264319","DOI":"10.3389\/fcvm.2023.1264319","volume":"10","author":"E Reijnders","year":"2023","unstructured":"Reijnders E, van der Laarse A, Jukema JW, Cobbaert CM. High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. Front Cardiovasc Med. 2023;10:1264319.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"7793_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/HCO.0000000000001080","volume":"38","author":"T Abrahams","year":"2023","unstructured":"Abrahams T, Fujino M, Nelson AJ, Nicholls SJ. Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging. Curr Opin Cardiol. 2023;38(6):504\u20138.","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"7793_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12350-017-1152-0","volume":"26","author":"T Khaing","year":"2019","unstructured":"Khaing T, Raymond CCW, Chan WX, Hao C, Wong SS. Quantification of myocardial blood flow and myocardial flow reserve with SPECT imaging technique. J Nuclear Cardiology: Official Publication Am Soc Nuclear Cardiol. 2019;26(1):318\u201323.","journal-title":"J Nuclear Cardiology: Official Publication Am Soc Nuclear Cardiol"},{"issue":"3","key":"7793_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00259-021-05511-z","volume":"49","author":"A Carabelli","year":"2022","unstructured":"Carabelli A, Canu M, de Fondaumi\u00e8re M, Debiossat M, Leenhardt J, Broisat A, Ghezzi C, Vanzetto G, Fagret D, Barone-Rochette G, et al. Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes. Eur J Nucl Med Mol Imaging. 2022;49(3):809\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"7793_CR26","doi-asserted-by":"publisher","first-page":"e2148139","DOI":"10.1001\/jamanetworkopen.2021.48139","volume":"5","author":"MB Mortensen","year":"2022","unstructured":"Mortensen MB, Ca\u00ednzos-Achirica M, Steffensen FH, B\u00f8tker HE, Jensen JM, Sand NPR, Maeng M, Bruun JM, Blaha MJ, S\u00f8rensen HT, et al. Association of coronary plaque with Low-Density lipoprotein cholesterol levels and rates of cardiovascular disease events among symptomatic adults. JAMA Netw Open. 2022;5(2):e2148139.","journal-title":"JAMA Netw Open"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07793-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:03:23Z","timestamp":1777316603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07793-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7793"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07793-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the First Hospital of Hebei Medical University (Approval No. 2024-S00492) and was registered in the Chinese Clinical Trial Registry (Registration No. ChiCTR2100045881). All procedures were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participating patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All patient data was anonymized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}